Tag: AndexXa
Portola Pharmaceuticals unveils data on Andexxa in patients with multiple types...
Portola Pharmaceuticals announced new data that they say reinforces the value of Andexxa (coagulation factor Xa , inactivated-zhzo). The company statement outlines that the...
Bristol-Myers Squibb and Pfizer provide US$50 million dollar loan to Portola...
Portola Pharmaceuticals has signed a US$50 million loan agreement with Bristol-Myers Squibb and Pfizer that provides additional funding toward development and clinical studies of...
Andexanet alfa study shows rapid and substantial anti-Factor Xa activity reversion
Portola Pharmaceuticals has announced interim results from the ongoing phase3b/4 ANNEXA-4 study of andexanet alfa (AndexXa), a Factor Xa inhibitor antidote.
In this study of...